The Pancreas and Liver Contain More Opioid Peptides Than the Brain — With Receptors for Blood Sugar Control
The pancreas and liver contain opioid peptide levels exceeding those in the brain, with functional delta and kappa receptors on pancreatic islets — suggesting a peripheral opioid system regulating blood sugar.
Quick Facts
What This Study Found
Pancreas and liver contain substantial opioid peptide levels exceeding brain content, with functional delta and kappa receptors on pancreatic islets. These peripheral opioids could regulate blood glucose.
Key Numbers
How They Did This
Radioligand displacement assays for receptor-active opioids, radioimmunoassay for specific peptides, radioligand binding for receptor subtypes, and immunogold electron microscopy for cellular localization.
Why This Research Matters
This proved that opioid peptides are not just brain chemicals. The pancreas has its own opioid system that likely helps regulate insulin, glucagon, and blood sugar levels.
The Bigger Picture
This study challenged the brain-centric view of opioid peptides. Finding higher opioid levels in metabolic organs than in the brain itself established that opioid peptides are major metabolic regulators, not just neurotransmitters. This has implications for understanding diabetes and the metabolic effects of opioid medications.
What This Study Doesn't Tell Us
Animal study in rats. The functional role of these peripheral opioids was not directly tested. The liver had peptides but no detectable receptors, leaving its opioid function unclear.
Questions This Raises
- ?Are pancreatic opioid peptide levels altered in type 2 diabetes?
- ?Could targeting pancreatic opioid receptors improve insulin secretion?
Trust & Context
- Key Stat:
- Pancreatic β-endorphin > brain levels The pancreas contained substantially more beta-endorphin than the brain, with functional opioid receptors on islet cells
- Evidence Grade:
- Moderate-strength study using multiple complementary methods (radioligand binding, immunoassay, electron microscopy). Compelling evidence for a peripheral opioid system.
- Study Age:
- Published in 1990. The pancreatic opioid system has been further characterized and is now recognized as a modulator of insulin secretion.
- Original Title:
- The occurrence and receptor specificity of endogenous opioid peptides within the pancreas and liver of the rat. Comparison with brain.
- Published In:
- The Biochemical journal, 267(1), 233-40 (1990)
- Authors:
- Khawaja, X Z(2), Green, I C(2), Thorpe, J R, Titheradge, M A
- Database ID:
- RPEP-00162
Evidence Hierarchy
Tests effects in animals (usually mice or rats), not humans.
What do these levels mean? →Frequently Asked Questions
Why would the pancreas need opioid peptides?
The pancreas must constantly fine-tune insulin and glucagon release to maintain blood sugar. Opioid peptides provide an additional layer of regulation, potentially helping coordinate the release of different hormones from different islet cell types.
Does this explain metabolic effects of opioid drugs?
Yes. Since the pancreas has its own opioid receptors, opioid medications can directly affect insulin and glucagon secretion. This helps explain why chronic opioid use is associated with metabolic changes and blood sugar dysregulation.
Read More on RethinkPeptides
Cite This Study
https://rethinkpeptides.com/research/RPEP-00162APA
Khawaja, X Z; Green, I C; Thorpe, J R; Titheradge, M A. (1990). The occurrence and receptor specificity of endogenous opioid peptides within the pancreas and liver of the rat. Comparison with brain.. The Biochemical journal, 267(1), 233-40.
MLA
Khawaja, X Z, et al. "The occurrence and receptor specificity of endogenous opioid peptides within the pancreas and liver of the rat. Comparison with brain.." The Biochemical journal, 1990.
RethinkPeptides
RethinkPeptides Research Database. "The occurrence and receptor specificity of endogenous opioid..." RPEP-00162. Retrieved from https://rethinkpeptides.com/research/khawaja-1990-the-occurrence-and-receptor
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.